Globe Life Inc.
NYSE:GLInsurance - Life
+$2.08 today
- Market cap
- $11.70B
- Beta
- 0.50
- P/E (TTM)
- 11.4
- EPS (TTM)
- $15.01
- Dividend yield
- 0.67%
Volume 0.81M
Average 0.53M
GL Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Globe Life Inc.NYSE: GL
Operating Expenses · Q3 FY2026 · quarter ended Sep 2026
Operating expenses growth accelerates
Q3 FY2026 operating expenses of $422.79M rose 186.3% year over year, ahead of the +28.3% change in trailing-twelve-month operating expenses. Over 3 fiscal years it compounded at +7.2% a year.
Context
- Operating expenses amounted to 9.0% of revenue in FY2025, down 0.4 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +186.3% holds above the trailing-twelve-month pace of +28.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 540.97M USD
- Year-over-year change
- -0.5%
- 4-year CAGR
- +7.0%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 540.97M | -0.5% |
| FY2024 | 2024-12-31 | 543.62M | +21.9% |
| FY2023 | 2023-12-31 | 445.98M | +1.6% |
| FY2022 | 2022-12-31 | 439.04M | +6.5% |
| FY2021 | 2021-12-31 | 412.4M | — |
Operating Expenses vs competitors
How GL compares with its peers on the latest reported figures
- GL's LTM Sep 2026 operating expenses of $756.62M is the lowest of the 11 companies compared; the peer median is $3.37B.
- Its year-over-year change of +28.3% is the 7th highest of 11, against a peer median of +59.2%.
- Operating expenses amounts to 12.0% of revenue for GL, versus a peer median of 37.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $15.23B | +9.8% | +22.9% | 19.4% | |
| LTM Jun 2026 | $14.96B | +8.2% | +1.2% | 23.1% | |
| LTM Jun 2026 | $8.29B | +148.3% | +134.2% | 42.8% | |
| LTM Jun 2026 | $5.67B | +302.8% | +70.6% | 87.1% | |
| LTM Jun 2026 | $3.82B | -7.8% | +23.0% | 28.9% | |
| LTM Jun 2026 | $2.91B | +180.7% | +12.6% | 77.3% | |
| LTM Sep 2026 | $2.41B | +85.8% | +28.8% | 44.4% | |
| LTM Jun 2026 | $1.66B | +25.8% | +20.8% | 35.8% | |
| LTM Jun 2026 | $1.38B | +32.7% | +65.3% | 23.0% | |
| LTM Sep 2026 | $1.33B | +245.8% | +72.8% | 38.5% | |
| LTM Sep 2026 | $756.62M | +28.3% | +7.2% | 12.0% | |
| Peer median (excluding GL) | $3.37B | +59.2% | +25.9% | 37.1% | |
Competitors are the stored peer set for GL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.12B | 5.23B | 5.45B | 5.78B | 6B |
| Cost of Revenue | 3.43B | 3.69B | 3.81B | 3.91B | 3.99B |
| Gross Profit | 1.69B | 1.54B | 1.64B | 1.87B | 2B |
| Gross Margin | 32.9% | 29.5% | 30.1% | 32.4% | 33.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 301.9M | 334.99M | 331.9M | 382.55M | 197.7M |
| Operating Expenses | 412.4M | 439.04M | 445.98M | 543.62M | 540.97M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 1.36B | 1.19B | 1.3B | 1.45B | 1.59B |
| EBITDA Margin | 26.5% | 22.8% | 23.8% | 25.2% | 26.5% |
| Operating Income | 1.27B | 1.1B | 1.19B | 1.33B | 1.46B |
| Operating Margin | 24.9% | 21.1% | 21.9% | 23.0% | 24.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 83.49M | 90.4M | 102.32M | 127.09M | 141.22M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (23.01M) |
| Income Before Tax | 1.27B | 1.1B | 1.19B | 1.33B | 1.44B |
| Pre-Tax Margin | 24.9% | 21.1% | 21.9% | 23.0% | 24.0% |
| Income Tax Expense | 243.5M | 207.73M | 223.51M | 255.88M | 278.57M |
| Net Income | 1.03B | 894.39M | 970.76M | 1.07B | 1.16B |
| Net Margin | 20.1% | 17.1% | 17.8% | 18.5% | 19.4% |
| EPS (Basic) | 7.30 | 9.13 | 10.21 | 11.99 | 14.30 |
| EPS (Diluted) | 7.22 | 9.04 | 10.07 | 11.94 | 14.06 |
| Weighted Avg Shares | 102.07M | 97.93M | 95.08M | 83.95M | 80.85M |
| Weighted Avg Shares (Diluted) | 103.17M | 98.98M | 96.36M | 84.75M | 80.85M |
Globe Life Inc.
NYSE:GL
Intrinsic Alpha fair value
Locked
Current Price
$155.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.